Company Filing History:
Years Active: 2008
Title: Carmen Diaz - Innovator in Protozoal Research
Introduction
Carmen Diaz is a notable inventor based in New York, NY (US). She has made significant contributions to the field of protozoal research, particularly in the development of novel cyclic GMP dependent protein kinases. Her work has implications for identifying potential antiprotozoal agents, which can be crucial in combating diseases caused by parasites.
Latest Patents
Carmen Diaz holds 1 patent related to her innovative research. The patent focuses on protozoal cyclic GMP dependent protein kinases and the genes encoding them. It also discloses nucleic acid molecules that encode such proteins, as well as antibodies raised against these proteins. The enzymes developed through her research may be utilized in screening assays to identify potential antiprotozoal agents. Additionally, the patent outlines methods to obtain these nucleic acid molecules, proteins, antibodies, and inhibitors, along with therapeutic compositions that can protect animals from diseases caused by parasites.
Career Highlights
Carmen Diaz is associated with Merial Limited, where she has been able to apply her expertise in protozoal research. Her work has been instrumental in advancing the understanding of protein kinases and their potential applications in medicine.
Collaborations
Carmen has collaborated with esteemed colleagues such as Paul A Liberator and Dennis M Schmatz. These collaborations have further enriched her research and contributed to the development of innovative solutions in her field.
Conclusion
Carmen Diaz is a pioneering inventor whose work in protozoal research has the potential to make a significant impact on the treatment of parasitic diseases. Her contributions to the field are invaluable and highlight the importance of innovation in scientific research.